Skip to main content
MediWound Ltd. logo

MediWound Ltd. — Investor Relations & Filings

Ticker · MDWD ISIN · IL0011316309 LEI · 549300LJKCS74GRYKF90 US Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2025-03-28 Regulatory Filings
Country IL Israel
Listing US MDWD

About MediWound Ltd.

https://www.mediwound.com/

MediWound Ltd. is a fully integrated biopharmaceutical company that develops, manufactures, and commercializes enzymatic therapeutics for non-surgical tissue repair. The company's core technology focuses on next-generation treatments that selectively remove eschar (non-viable tissue) from severe burns and chronic wounds while preserving healthy tissue. This approach is designed to accelerate healing, improve patient outcomes, and lower overall healthcare costs. Its primary commercial product is a topical biologic for the debridement of severe thermal burns. MediWound maintains a research and development pipeline aimed at expanding its enzymatic platform to address additional unmet medical needs in wound care.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings
2025-03-28 English
Regulatory Filings 2025
Regulatory Filings Classification · 100% confidence The document is a letter from MediWound Ltd. to the SEC requesting acceleration of the effective date of a Registration Statement on Form F-3. It references a registration number and a specific regulatory rule (Rule 461 of Regulation C under the Securities Act of 1933). The content is a formal regulatory communication related to securities registration and does not contain financial statements, earnings data, or detailed report content. The document length is short (1448 characters) and it is clearly an official regulatory filing or correspondence rather than a full report or announcement of financial results. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-03-25 English
Regulatory Filings 2025
Regulatory Filings
2025-03-24 English
F-3
Capital/Financing Update Classification · 100% confidence The document is a Form F-3 Registration Statement filed with the SEC under the Securities Act of 1933. It is a shelf registration prospectus for offering securities, including ordinary shares, warrants, and debt securities, by MediWound Ltd. The text includes detailed information about the offering, the company, risk factors, and legal disclaimers. This type of filing is related to capital raising and financing activities rather than financial reporting, management changes, or other categories. Therefore, it fits the Capital/Financing Update (CAP) category.
2025-03-19 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as share incentive plans. It details the registration of ordinary shares under the MediWound Ltd. 2024 Share Incentive Plan, including information about the plan, incorporation by reference of other filings, indemnification of directors and officers, and exhibits related to the plan. This type of filing is specifically for registering securities for employee compensation plans and is not a financial report, earnings release, or other types of filings. According to the filing definitions, Form S-8 registrations fall under the category of Regulatory Filings (RNS) as they are general regulatory announcements and compliance documents that do not fit into other specific categories. The document is substantive and not a mere announcement, but it is not a financial report or management information either. Therefore, the correct classification is Regulatory Filings (RNS).
2025-03-19 English
20-F
Annual Report FY 2024
2025-03-19 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.